Abstract
We characterized Escherichia coli ST131 isolates among 116 carbapenemase-producing strains. Of isolates from 16 countries collected during 2008-2013, 35% belonged to ST131 and were associated with blaKPC, H30 lineage, and virotype C. This study documents worldwide incidents of resistance to "last resort" antimicrobial drugs among a common pathogen in a successful sequence type.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Bacterial Proteins / genetics*
-
Escherichia coli / drug effects
-
Escherichia coli / genetics*
-
Escherichia coli / isolation & purification
-
Escherichia coli Infections / epidemiology*
-
Escherichia coli Infections / microbiology*
-
Global Health
-
Humans
-
Incidence
-
Microbial Sensitivity Tests
-
beta-Lactam Resistance / genetics
-
beta-Lactamases / genetics*
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
beta-Lactamases
-
carbapenemase